A recent study showed that estrogen increases the levels of GLI1 and GLI2 in several ER-positive BC cell lines [110], whereas inhibition of GLI1 and GLI2 activity with GANT61 reduced the number of mammosphere-forming CSC in the cultures. This evidence concerns the gene ESR1 and breast cancer.